Pharmacokinetics of Atorvastatin With Tipranavir/Ritonavir and the Effect of Antacid on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir in Healthy Volunteers

• Status: Completed
• Trial end date: 1969-12-31

Summary

Study to determine the effects of combined tipranavir and ritonavir treatment (at steady-state) on the single-dose pharmacokinetics of atorvastatin, the effects of single-dose atorvastatin on the steady-state pharmacokinetics of tipranavir, and the effects of antacid on the pharmacokinetics of tipranavir

• Phase: Phase 1

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Aluminum hydroxide, magnesium hydroxide, drug combination; Antacids; Anti-Ulcer Agents; Atorvastatin; Atorvastatin Calcium; Ritonavir; Tipranavir